Nicorandil (XT-FL515)
Features
Through product innovation, we can enhance the added value of 4,7-bis(5-bromothiophen-2-yl)-5,6-dinitro-2,1,3-benzothiadiazole, CAS: 1674-37-9, 4-acetyl-2-methyl Benzoic Acid and improve the market competitiveness of products. The pursuit of value is the starting point of our work, and the creation of value is the driving force of our business. Our goods will continue to increase in the order and look forward to cooperation with you. On the new journey, we lead the way forward, adhering to the glorious mission of sincerely serving the industry, promoting the spirit of enterprise, and being brave to pioneer.
Name: Nicorandil
CASNO:65141-46-0
Purity:97% min
MF:C8H9N3O4
MW:211.175
BP:456.7±25.0 °C at 760 mmHg
Density:1.3±0.1 g/cm3
MP:92ºC
EINECS:N/A
Appearance:white or off-white powder
Package:25g, 100g, 500g, bulk package
Application:Pharmaceutical intermediate
Storage Condition: Desiccate at +4ºC
Othername:
2-(pyridine-3-carbonylamino)ethyl nitrate;
Ikorel;
SG-75;
Dancor;
Nikoran;
Nicorandilum;
N-(2-hydroxyethyl)nicotinamide nitrate ester;
Adancor;
N-[2-(nitroxy)ethyl]-3-pyridine carboxamide;
2-Nicotinamidoethyl nitrate;
Nicorandil CAS NO: 65141-46-0 is a vasodilatory drug used to treat angina. It is marketed under the trade names Ikorel (in the United Kingdom, Australia and most of Europe), Angedil (in Romania, Poland), Dancor (in Switzerland), Nikoran,PCA (in India), Aprior (in the Philippines), Nitorubin (in Japan), and Sigmart (in Japan, South Korea and Taiwan). Nicorandil CAS NO: 65141-46-0 is not available in the United States.
Angina is chest pain that results from episodes of transient myocardial ischemia. This can be caused by diseases such as atherosclerosis, coronary artery disease and aortic stenosis. Angina commonly arises from vasospasm of the coronary arteries. There are multiple mechanisms causing the increased smooth muscle contraction involved in coronary vasospasm, including increased Rho-kinase activity. Increased levels of Rho-kinase inhibit myosin phosphatase activity, leading to increased calcium sensitivity and hypercontraction. Rho-kinase also decreases nitric oxide synthase activity, which reduces nitric oxide concentrations. Lower levels of nitric oxide are present in spastic coronary arteries. L-type calcium channel expression increases in spastic vascular smooth muscle cells, which could result in excessive calcium influx, and hypercontraction.
Nicorandil CAS NO: 65141-46-0 is an anti-angina medication that has the dual properties of a nitrate and K+ATP channel agonist. In humans, the nitrate action of nicorandil dilates the large coronary arteries at low plasma concentrations. At high plasma concentrations nicorandil CAS NO: 65141-46-0 reduces coronary vascular resistance, which is associated with increased K+ATP channel opening.